Olema Pharmaceuticals (NASDAQ:OLMA) Price Target Lowered to $28.00 at JPMorgan Chase & Co.
Olema Pharmaceuticals (NASDAQ:OLMA – Get Free Report) had its price objective decreased by equities research analysts at JPMorgan Chase & Co. from $30.00 to $28.00 in a note issued to investors on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Several other equities research analysts have also recently commented on the […]
